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Abstract
Atypical protein kinase C (aPKC) isoforms have been implicated in cell polarisation and migration through association with
Cdc42 and Par6. In distinct migratory models, the Exocyst complex has been shown to be involved in secretory events and
migration. By RNA interference (RNAi) we show that the polarised delivery of the Exocyst to the leading edge of migrating
NRK cells is dependent upon aPKCs. Reciprocally we demonstrate that aPKC localisation at the leading edge is dependent
upon the Exocyst. The basis of this inter-dependence derives from two-hybrid, mass spectrometry, and co-
immunoprecipitation studies, which demonstrate the existence of an aPKC–Exocyst interaction mediated by Kibra. Using
RNAi and small molecule inhibitors, the aPKCs, Kibra, and the Exocyst are shown to be required for NRK cell migration and it
is further demonstrated that they are necessary for the localized activation of JNK at the leading edge. The migration
associated control of JNK by aPKCs determines JNK phosphorylation of the plasma membrane substrate Paxillin, but not the
phosphorylation of the nuclear JNK substrate, c-jun. This plasma membrane localized JNK cascade serves to control the
stability of focal adhesion complexes, regulating migration. The study integrates the polarising behaviour of aPKCs with the
pro-migratory properties of the Exocyst complex, defining a higher order complex associated with the localised activation of
JNK at the leading edge of migrating cells that determines migration rate.
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Introduction
Migration of cells is critical to the development and the normal
physiology of organisms; it also plays a more sinister role in the
dissemination of cancer towards metastatic disease, a process
typically associated with poor prognosis. The process of migration
involves a combination of cellular functions including those of
altered attachment to surrounding contacts (cells or matrix),
protrusion of a leading edge, polarisation in the creation or
recognition of that leading edge, and mechanical movement [1].
Understanding the details of these processes represents an
important objective in defining the collection of candidate targets
that may offer new opportunities in restricting disease spread.
The atypical PKC isoforms (aPKCf and aPKCi) comprise a
branch of the serine/threonine protein kinase PKC superfamily
with regulatory properties that distinguish them from the more
typical diacylglycerol-regulated isoforms [2]. These kinases can be
activated by acidic phospholipids such as the polyphosphoinosi-
tides [3], however specificity appears to be driven by activation
through Par6/cdc42 [4]. Indeed, interactions with the Par6/Par3
complex have implicated aPKC isoforms in a number of polarity
[5] and more recently migratory models [6]. In migrating
astrocytes, the activation of aPKC leads to phosphorylation and
inactivation of GSK-3b, which causes the adenomatous polyposis
coli (APC) tumor suppressor protein to associate with microtubule
plus ends at the leading edge [7]. The Par6-PKCf complex also
regulates the spatially localized association of Dlg1 and APC to
control cell polarization [8]. PKCf is required for epidermal
growth factor-induced chemotaxis of human breast cancer cells
[9], while PKCi has been shown to promote nicotine-induced
migration and invasion of cancer cells via phosphorylation of m-
and m-calpains [10].
The Exocyst was first identified as a complex required for
exocytosis in Saccharomyces cerevisiae [11]. In mammals, the Exocyst
PLoS Biology | www.plosbiology.org 1 November 2009 | Volume 7 | Issue 11 | e1000235comprises a complex of eight proteins, which facilitates regulated
exocytosis to regions of membrane activity [12,13,14,15]. Recently
it has been shown that a Ral-Exocyst pathway is involved in cell
migration, with RalB activation leading to Exocyst assembly and
recruitment to the leading edge [16].
It is anticipated that the various complexes and pathways
involved in polarized migration may be co-regulated/coordinated
and that elucidation of these relationships will lead to a more
integrated understanding of migratory behaviour. The present
study was stimulated by the finding that the scaffold protein Kibra,
previously shown to interact with aPKCf [17], was a binding
partner of the Exocyst (see below). This has led to the specific
hypothesis that there is a molecular and functional interaction
between the Par/CDC42/PKCf/i pathway and the Ral/Exocyst
pro-migratory pathways. We demonstrate that indeed there is a
mutual dependence of aPKC and Exocyst in their behaviour in
migratory cells and this is associated with their mutually
dependent regulation of the delivery of signals to the leading edge
of migrating cells. We identify key regulatory processes under the
control of these local aPKC/Exocyst-dependent signals and go on
to demonstrate that the regulation of focal adhesion stability
represents a critical migratory output of the aPKC/Exocyst
pathway.
Results
Atypical PKCs Are Necessary for NRK Cell Migration
A cooperative functional relationship between the Exocyst
complex and aPKC in cell migration should be reflected in a
shared requirement in a model system. The Exocyst has been
shown previously to play an essential role in NRK cell migration.
So to determine the requirements for PKCi and PKCf in NRK
cell migration, two independent siRNAs for each protein were
employed to knock-down expression (Figure 1A). Depletion of
either PKCi or PKCf resulted in a cell migration defect as
assessed in a monolayer wound healing model (Figure 1B) as well
as in a Transwell migration assay (unpublished data). The speed of
NRK cell migration in the wound assay is 15.3 mm/h. Depletion
of either aPKC reduces this by ,40%, whilst depletion of both
reduces migration further to ,6 mm/h (Figure 1C).
To distinguish between a non-catalytic, scaffold-only require-
ment for aPKC and a catalytic activity requirement, PKC
inhibitors were employed. Selected combinations of these
inhibitors can be exploited to provide circumstantial evidence on
the requirements of PKC isoforms based upon their relative
potency such that an aPKC activity involvement would be
sensitive to the pan-PKC inhibitor Go ¨6983 (cPKC, nPKC, aPKC)
while showing little sensitivity to BIMI (cPKC, nPKC) or Go ¨6976
(cPKC). Go ¨6983 had a profound effect on cell migration, while the
cPKC inhibitor Go ¨6976 had no effect (Figure 1C and 1D). BIMI
had a weaker effect than the Go ¨6983 on migration (Figure 1C and
1D). Although these inhibitors are not entirely PKC-specific, in
combination with the siRNA data it can be concluded that aPKCs
are required for efficient NRK cell migration, providing a model
in which to probe an aPKC-Exocyst relationship in migration.
aPKCs and the Exocyst Complex Are Recruited to the
Leading Edge of Migrating Cells in a Mutually Dependent
Manner
To assess a connection between aPKC isoforms and the
Exocyst, we sought to determine their distribution in migrating
cells. Examination of the location of aPKCs (combined PKCi and
PKCf) demonstrated that aPKC was localised at the leading edge
of migrating NRK cells (Figure 2A). By contrast, in confluent cells,
aPKCs are mainly cytosolic and sometimes partially at cell-cell
contacts (unpublished data). A monoclonal antibody specific for
PKCi confirmed its presence at the leading edge as well as within a
perinuclear compartment; PKCf specific reagents were found to
cross-react with recombinant PKCi precluding PKCf-specific
immunostaining (Dr. M. Linch and PJP unpublished results). The
Exocyst (here visualized by the subunits Sec6 and Exo70) is also in
part localized at the leading edge of migrating cells and the pattern
of aPKC distribution matches that observed for the Exocyst
complex. The localisation of aPKC and the Exocyst at the leading
edge of migrating cells is not simply a function of membrane
ruffling. In subconfluent monolayers extensive membrane ruffling
is observed without enrichment of aPKC or the Exocyst (Figure
S1), while the ruffles at the leading edge of migrating cells are
enriched with aPKC and the Exocyst.
To determine whether the Exocyst was responsible for aPKC
accumulation at the leading edge, siRNA to Sec5 was employed
[16]. Knock-down of Sec5 (Figure 2A) prevented aPKC
localisation at the leading edge without disturbing the total
amount of aPKC in the cells (Figure 2B). Knock-down of another
component of the Exocyst complex, Exo84, also prevented aPKC
localisation at the leading edge (see below, Figure 3C). When one
of the components of Exocyst complex (either Sec5 or Exo84) is
depleted, more than 50% of the cells have a total absence of PKCi
at the leading edge. Consistent with this, migration was inhibited
on knock-down of Sec5 and Exo84 by 60%. Reciprocally it was
found that siRNA to aPKCs (Figure 2C and Figure S2A, S2C) or
treatment with the inhibitor Go ¨6983 (unpublished data) sup-
pressed Exo70 (for more than 60% of the cells) and Sec6
accumulation at the leading edge. This disruption of localisation is
not due to a modification of the protein levels of Exo70 and Sec6
Author Summary
Cell migration is an essential process in multicellular
organisms during such events as embryonic develop-
ment, the immune response, and wound healing. Cell
m i g r a t i o ni sa l s oi n s t r u m e n t a li nt h ed e v e l o p m e n to f
pathologies such as cancer cell invasion of healthy
tissues. To make cells move, key molecules must be
engaged in a coordinated manner; understanding which
molecules, and how and when they work (for example,
under physiological versus pathological conditions) will
impact on new therapies designed to suppress abnormal
migration. Migrating cells must coordinate two key
processes: extension of the front or ‘leading’ edge of
the cell and retraction of the back edge. Both processes
require the turnover of protein assemblies known as focal
adhesion complexes. In this paper we show that two
different groups of regulators of migration – aPKC, a
protein kinase, and exocyst, a complex of proteins also
known to be required for exocytosis – interact physically
via the scaffold protein kibra. All these components are
required for efficient cell migration and all are enriched at
the leading edge of moving cells, in a mutually
dependent manner. At the leading edge, these compo-
nents control the local activation of two additional
protein kinases, ERK and JNK. The activation of ERK and
JNK at the front of migrating cells in turn controls the
phosphorylation of paxillin, a component of focal
adhesions. Phosphorylation of paxillin is associated with
t h ep r e s e n c eo fm o r ed y n a m i cf o c a la d h e s i o n s .O u rd a t a
thus indicate that an aPKC-kibra-exocyst complex plays a
crucial role in delivering local stimulatory signals to the
leading edge of migrating cells.
An aPKC-Exocyst Complex Promotes Cell Migration
PLoS Biology | www.plosbiology.org 2 November 2009 | Volume 7 | Issue 11 | e1000235Figure 1. aPKCs are required for cell migration. (A) siRNA specificity and efficiency in NRK cells. For the siRNA experiments, NRK cells were
transfected with the indicated siRNAs. After 72 h, whole-cell extracts were analyzed by immunoblotting with the indicated antibodies. (B) Depletion
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edge were quantified (Figure S2A, S2B, S2C). We also evaluated
the specificity of the staining as well as the effect on the knock-
down of the Exocyst (Sec5 or Exo84) on the presence of aPKC at
the leading edge and reciprocally the effect on the knock-down of
aPKC on the presence of Exo70 at the leading edge (Figure S2A,
S2B). Notably, depletion of either PKCi or PKCf partially
inhibited the ‘‘tubularisation’’ of the Sec6 compartment seen in
motile cells on methanol fixation (Figure S3C), suggesting that
aPKC is required for the localization of Sec6 on microtubules in
response to cell migratory cues. Depletion of PKCi or PKCf or
Sec5 did not dramatically affect the stability of the microtubules
(unpublished data). To control for the possibility of global
disruptive effects of aPKC on vesicle-staining patterns in migrating
cells, b-COP proteins were monitored. The depletion of aPKC
modified the localization of Sec6 but not b-COP, indicating the
specificity of the aPKC effect (Figure S3C).
The Recruitment of aPKCs and the Exocyst Complex at
the Leading Edge Are Dependent on Microtubules
The Exocyst associates with microtubules [18,19] providing a
potential basis for Exocyst and aPKC movement. As predicted,
of PKCf, PKCi, or depletion of both inhibits wound healing. Confluent monolayers of NRK cells transfected with the indicated siRNA were wounded
60 h post-transfection (T0), and healing was followed over time. T12 refers to the time 12 h post-wounding. The panels shown are representative of
at least three independent experiments. (C) Quantitation of migration speed and the effects of aPKC knock-down or inhibitors is summarized in the
panel. (D) Quantitation of migration persistence and the effects of aPKC knock-down are summarized in the panel. (E) NRK cells were pretreated for
6 h with Go ¨6976 (5 mM; cPKC inhibition), BIM (5 mM; c/nPKC inhibition), or Go ¨6983 (5 mM; c/n/aPKC inhibition) and then the confluent monolayers
were wounded. The healing was followed over 12 h. TO and T12 refer, respectively, to the times 0 h and 12 h post-wounding. The panels shown are
representative at least of three independent experiments.
doi:10.1371/journal.pbio.1000235.g001
Figure 2. Mutual, microtubule dependent control of aPKC and the exocyst at the leading edge. (A) Monolayers of NRK cells were
wounded 60 h post-transfection with the indicated siRNAs (10 nM). Cells were fixed 6 h after wounding, and the indicated proteins were detected
with specific antibodies. PKCf and PKCi are recruited at the leading edge and these recruitments are dependent on the presence of Sec5. (B) siRNA
specificity and efficiency in NRK cells. For the siRNA experiments, NRK cells were transfected with the indicated siRNAs. After 72 h, whole-cell extracts
were analyzed by immunoblotting with the indicated antibodies. (C) Monolayers of NRK cells were wounded 60 h post-transfection with the
indicated siRNAs (10 nM). Cells were fixed 6 h after wounding with paraformaldhehyde, permeabilized by Triton6100 1%, and then immunostained
for Sec6 or aPKC. (D–F) Monolayers of NRK cells were wounded, and 5 h post-wounding, cells were treated for 1 h with nocodazole (10 mM). Cells
were then fixed with paraformaldhehyde, and Exo70, P-JNK1/2, and PKCi were detected with specific antibodies. (E) Cells were fixed with methanol
and stained for Sec6 and Fitc-tubulin.
doi:10.1371/journal.pbio.1000235.g002
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PLoS Biology | www.plosbiology.org 4 November 2009 | Volume 7 | Issue 11 | e1000235Figure 3. The Exocyst interacts with active aPKC via kibra in a migration-dependent manner. (A) Protein extracts from NRK cells were
immunoprecipitated with anti-Sec8 or anti-myc antibodies and the immunoprecipitates were analysed for the presence of PKCe, PKCd, and PKCf/i by
Western blotting. (B) The Exocyst was recovered by immunoprecipitation of Sec8 and associated kinase activity was assessed in the presence of
32P-
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found to block the accumulation of Exo70 at the leading edge
(Figure 2D). Using methanol fixation, Sec6 is detected on tubular
structures and these ‘‘tubules’’ of Sec6 are also dependent on the
stability of the microtubules (Figure 2E). Because aPKCs were
described to control MTOC orientation via the Dynein-Dynactin
complex [20] and the recruitment of the Exocyst complex is
dependent on the microtubule network, it is possible the effect of
the depletion of aPKC on the recruitment of the Exocyst at the
front of the cells is due to an indirect effect of aPKC on motor
proteins. However, the presence of dominant negative CDC42,
which is involved in aPKC effects on polarity, did not disturb the
localization of Exo70 at the leading edge (Figure S3D). As
predicted from the observations above, nocodazole treatment also
blocks aPKC delivery to the leading edge (Figure 2F). The
specificity of nocodazole treatment is reflected in the finding that
treatment increases actin stress fibres showing that cells retained
microfilament structures (unpublished data).
A Regulated Interaction of aPKCs and the Exocyst
Complex in Cells
To investigate the basis of the mutual aPKC-Exocyst localisation
relationship, assessment was made of the possible association of
aPKC and the Exocyst in NRK cells. Antibodies to the Exocyst
subunit Sec8 efficiently immunoprecipitated the native complex;
probing this immunopurified complex for the presence of aPKC
showedthataPKCwasalsoassociated.BycontrasttherelatedPKCe
and PKCd, which are also expressed in NRK cells, were not
recovered in association with the immunopurified Exocyst complex
(Figure 3A). Sec8 interacts with both PKCi and PKCf,b a s e do n
immunoprecipitation from NRK cells expressing PKCi or a myc
tagged PKCf construct(Figure S4A and S4B). Immunoprecipitation
with anti-mycPKCf or PKCi antibodies did not recover detectable
Sec8inthe immunoprecipitate;itwouldseem that onlyasubfraction
ofPKCi orPKCf is complexed to Sec8. Directdemonstration of the
interaction in cells employing FRET approaches has not proved
possible because the GFP-fusions of Exocyst subunits have been
foundnottoenterintomatureExocystcomplexes(unpublisheddata)
in contrast to the findings in yeast [21].
Given the predicted requirement for activity in the migratory
behaviour described above, it was important to determine whether
the Exocyst associated aPKC was catalytically active. MBP was
selectively phosphorylated in Sec8 immunoprecipitates and this
phosphorylation was inhibited by a peptide inhibitor of aPKC
(Figure 3B). The Sec8-associated aPKC thus appears to be active.
To assess if the interaction between aPKCs and the Exocyst is
regulated, we examined activity and migratory requirements. Sec8
was immunoprecipitated following treatment with the inhibitor
Go ¨6983. As shown in Figure S4C, the physical interaction
between Sec8 and aPKC is not modulated in the absence of
aPKC activity. To examine if cell migratory cues impact the
stability of the interaction between the Exocyst and aPKC, a
monolayer of confluent NRK cells was extensively scratched to
maximize the number of ‘‘free edges’’ where cell-cell contacts are
released. As shown in Figure 3C, cell migration promoted the
interaction between aPKC and the Exocyst at 3 h and 6 h. The
interaction with the Exocyst increased 1.5- to 2-fold (PKCi or both
aPKCs) 6 h after monolayer wounding (Figure 3D). This increase
of interaction during cell migration does not appear to be a non-
specific stress response triggered by the multi-scratch assay, since
no such influence is exerted by osmotic shock (unpublished data).
These results sustain the idea that the function of these proteins
requires their interaction during cell migration.
aPKCs Interact with the Exocyst Complex Via Kibra,
Which Is Also Required for Cell Migration
The Sec3 subunit of the Exocyst was used as a bait in a two-
hybrid screen of a highly complex human placenta cDNA library
(10 million independent clones). A total of 120 million interactions
were screened (12 times library coverage) and four clones encoding
human Kibra (NP_056053) were identified; Kibra is a known
aPKC binding partner [17,22]. Kibra’s domain of interaction with
Sec3 was defined by the smallest identified prey fragment and
encompasses amino acids 129–526. This region has been found
only in six screens amongst 935 screens performed against the
same cDNA library, indicating that the Sec3-Kibra interaction is
highly specific (Figure 3E). In the same screen with Sec3 as a bait,
expected partners such as Sec5 (12 fragments, 4 different fusions;
interacting domain is amino acids 96–252) and Sec8 (7 fragments,
2 different fusions; interacting domain is amino acids 28–167) were
identified also. Confirmation of this Exocyst complex has come
from independent studies as Kibra was identified as a partner of
the Exocyst from an unbiased proteomic analysis of Exocyst-
interacting proteins [23]. To determine the retention of this Kibra
interaction in the context of the Exocyst complex, we submitted
protein extracts from NRK cells expressing Myc-Kibra or Flag-
Kibra constructs to immunoprecipitation with anti-Myc or Flag
antibody and the immunoprecipitates were analyzed for the
presence of Sec8 (a component of the complex but not Sec3 itself).
Figure S5A and S5B show that ectopically expressed Myc-Kibra
or Flag-Kibra co-immunoprecipitate with Sec8, whereas the beads
alone or a myc antibody used as a negative control precipitated
neither. For consistency, we tested if the interaction between Kibra
and Exocyst (Sec8) and also between Kibra and aPKC are
dependent on cell migration. As shown in Figure 3F, cell migration
promoted the interaction between aPKC and Myc-Kibra and also
that between Myc-Kibra and Sec8.
To ensure these observations were not a function of ectopic
expression, we investigated the behaviour of the endogenous
proteins. Endogenous Kibra was found to interact with Sec8 and
aPKC, and this complex also increased during cell migration as
observed above for the overexpressed Kibra (Figure 3F and 3G).
This result sustains the idea that the function of these proteins
requires their interaction during cell migration and is entirely
consistent with the increased interaction between Sec8-aPKC
during cell migration (Figure 3C).
ATP and an exogenous PKC substrate, MBP, either in the presence or absence of an aPKC inhibitor. (C) As previously described [16], a monolayer of
confluent NRK cells was extensively scratched to maximize the number of ‘‘free edges’’ where cell-cell contacts were released. Sec8 was
immunoprecipitated and PKCi and PKCf/i were detected by Western blot. The loading of the cell extracts represents 10% of the input for
immunoprecipitation. (D) Quantitation of three experiments as described in (C). (E) Depiction of the domains of interaction between Kibra/Sec3 and
also between Kibra/PKCf. (F) A monolayer of confluent NRK cells overexpressing Myc-Kibra was extensively scratched to maximize the number of
‘‘free edges’’ where cell-cell contacts were released. Myc-Kibra was immunoprecipitated and Sec8 was detected by Western blot. (G) NRK cells were
transfected with a siRNA against Kibra or an siRNA control as indicated. Seventy-two h after transfection, the monolayers of confluent NRK cells were
extensively scratched to maximize the number of ‘‘free edges’’ where cell-cell contacts were released. Sec8 was subsequently immunoprecipitated,
and associated aPKCs were detected by Western blot. (H) Immunoprecipitates of Sec8 were performed from cells treated with an siRNA directed at
Kibra or with a luciferase siRNA control as indicated. Immunocomplexes were then probed for atypical PKC and Sec8 itself.
doi:10.1371/journal.pbio.1000235.g003
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defined by two-hybrid resides within the amino acid sequence
129–526 and the region of Kibra that binds PKCf encompasses
amino acids 953–996, there is no apparent conflict for Kibra in
binding both PKCf and Sec3. To assess whether the endogenous
aPKCs are associated with the endogenous Exocyst via Kibra, we
submitted protein extracts from scratch wounded NRK cells,
depleted or not of endogenous Kibra, to immunoprecipitation
with anti-Sec8. The immunoprecipitates were analyzed for the
presence of PKCf/i. The interaction between Sec8 and PKCf/i
decreased on depletion of Kibra, demonstrating that Kibra
contributes to complex formation (Figure 3G and Figure S5D).
Based upon this requirement for Kibra, it was predicted that
Kibra knock-down by siRNA would inhibit migration and this was
found to be the case (Figure 4A, 4B, and 4E). The fact that there
was consistently only a 25% decrease in cell migration in the
absence of Kibra using different knock-down strategies suggests
that an alternate protein(s) might also participate in the complex
between the Exocyst and aPKC.
We sought to assess the relevance of the aPKC-Kibra
interaction in the context of the localisation of aPKC in migrating
cells. As previously shown in podocytes [24], endogenous Kibra
was found to be recruited to the leading edge as well in NRK cells.
Endogenous Kibra colocalised with aPKC in an Exocyst
dependent manner (Figure 4D). The depletion of aPKC decreased
the recruitment of Kibra at the leading edge (Figure 4C, 4D, and
4E) consistent with the lack of recruitment of the Exocyst under
these conditions (see above). Interestingly, overexpression of Myc-
Kibra or Flag-Kibra inhibits NRK cell migration (Figure 4B),
consistent with interference in the bivalent interaction observed
here. To address this point, examination of the location of aPKCs
(combined PKCi and PKCf) demonstrated that aPKC was
colocalised at the leading edge of migrating NRK cells when
Myc-Kibra is weakly overexpressed but the recruitment of aPKC
at the leading edge is disturbed when Myc-Kibra is strongly
overexpressed (Figure S5C). Finally, to determine whether Kibra is
responsible for aPKC delivery to the leading edge, siRNA to Kibra
was employed. Knock-down of Kibra inhibited aPKC localisation
at the leading edge (Figure 4C, 4E).
Atypical PKCs Control the Local Activation of JNK1 and
ERK1/2 at the Leading Edge
The function of the leading edge aPKC-Kibra-Exocyst complex
was assessed in relation to the activation of the JNK pathway, since
there is evidence both for aPKC involvement in JNK control in
other contexts (e.g. in response to TNF or IL1 [25,26]), as well as
for JNK involvement in migration [27,28,29,30]. In response to
wound healing (multiple scratch wounds), JNK1 and JNK2 were
activated in a biphasic fashion (Figure 5A). The effect of
acute inhibition of aPKC was assessed using Go ¨6983 and for
comparison the non-aPKC directed inhibitors, Go ¨6976 (Figure 5A)
and BIMI (unpublished data). The inhibition of atypical, novel,
and classical PKCs suppressed the activation of JNK1 without
affecting JNK2. By contrast the PKC inhibitors not directed at the
aPKCs, Go ¨6976, and BIMI modestly increased JNK1 phosphor-
ylation (Go ¨6976 decreases JNK2 activation while BIMI had no
such effect, indicative of a non-PKC dependent effect). On
depletion of JNK1 by siRNA, the P-JNK1 immunoreactivity was
also decreased indicating that the doublet identified by western is
JNK1 and a splice variant/modified form of JNK1 (Figure S7D).
Inhibiting aPKC (Go ¨6983), but not non-aPKC family members
(Go ¨6976 nor BIM1), also affected the activation of ERK1/2
during cell migration (Figure S4D, S4E). None of these PKC
inhibitors influenced the p38 pathway response in migrating
NRK cells, indicative of specific pathways wherein aPKC
activity is required for JNK1 and ERK1/2 activation during
migration.
The effects of aPKC on JNK1 were reflected in the altered
localised activation of JNK1/2 in migrating cells; under control
conditions, JNK was found to accumulate in a phosphorylated
state at the leading edge and this localised activation was lost on
depletion of PKCf, PKCi, Sec5, Exo84, or Kibra (Figure 5B–5D;
see also Figure 6C, Figure S6A). Notably the depletion of these
proteins did not influence the accumulation of active JNK in the
nucleus, consistent with a lack of effect of Go ¨6983 on global JNK2
activation determined by Western. This Exocyst/Kibra/aPKC-
dependence was also observed for the phosphorylation of ERK1/2
at the leading edge of migrating cells (Figure 5B–5D; see also
Figure S6A). Quantitation of these responses is detailed in Figure
S8. This confirms that there is a strong decrease of P-JNK and P-
ERK at the leading edge without a significant disruption of the
recruitment of the total ERK and JNK proteins at the leading
edge (see below). It is noted that this demonstrates that this
polarised leading edge in the migrating cells is still present even
when aPKC and the Exocyst are non-functional. We confirmed
the specificity of the phospho-specific antibody against P-ERK1/2
by using the MEK inhibitor U0126 and found that it suppressed
the P-ERK staining (Figure S6B). We confirmed the specificity of
the phospho-specific antibody against P-JNK1/2 by using a
phospho-JNK (Thr183/Tyr185) blocking peptide and found that
it suppressed the P-JNK staining (Figure S7F). Also, following
depletion of JNK1 by siRNA, the staining of P-JNK at the leading
edge decreased (Figure S7G). The controls monitoring the reduced
protein expression associated with siRNA treatment is illustrated
in Figure S7A and S7B (it is notable that Exo84 is reduced on Sec5
depletion suggesting that uncomplexed Exo84 may be subject to
degradation).
This aPKC/Exocyst-dependent localised phosphorylation of
MAPKinases (phosphorylated ERK1/2, as well as phosphorylated
JNK) may be a consequence of their movement to the leading
edge or of their activation at the leading edge. To distinguish
between these two possibilities, the localisation of the kinases
(phosphorylated and non-phosphorylated) was assessed in control
cells or following aPKC, Kibra, Sec5, or Exo84 knock-down
(protein depletion on knock-down is illustrated in Figure S7A and
S7B). No effects on MAPkinase protein distribution were observed
(Figure S6C, S6D, and S6E). Figure S6E shows that when the
Exocyst/Kibra/aPKC is disrupted, P-ERK1/2 decreased at the
leading edge whereas the non-phosphorylated form remained at
the leading edge (note that the P-ERK1/2 staining appears a little
different from that in Figure 5B–5D due to methanol fixation
instead of paraformaldehyde fixation; the methanol fixation is
better for the total ERK1/2 whereas the paraformaldehyde gave
better staining for the P-ERK1/2). This result showed that cells
retain a leading edge allowing the recruitment/retention of JNK
and ERK proteins independent of the Exocyst and aPKC. Hence
it is the localised activation that is critically under aPKC-Kibra-
Exocyst control.
Analysis of the relevant upstream kinase(s) in the JNK pathway
identified MKK4 and not MKK7 as showing increased phos-
phorylation after wounding (Figure 5A). Linking to aPKC
function, wound-associated activation of MKK4 during cell
migration is sensitive to the a/n/cPKC inhibitor Go ¨6983
(Figure 5A); Go ¨6976 (n/cPKC inhibitor) has no such effect (in
fact it has the opposite effect to Go ¨6983, increasing the
phosphorylation of MKK4). The constitutive phosphorylation of
MKK7, the other JNK-kinase, was insensitive to Go ¨6983
(unpublished data).
An aPKC-Exocyst Complex Promotes Cell Migration
PLoS Biology | www.plosbiology.org 7 November 2009 | Volume 7 | Issue 11 | e1000235Figure 4. Kibra is required for cell migration and for the recruitment of aPKC at the leading edge. (A) Depletion of Kibra inhibits wound
healing. Confluent monolayers of NRK cells transfected with the indicated siRNAs were wounded 60 h post-transfection (T0) and migration was
followed over time. T20 refers to the time 20 h post-wounding. The panels shown are representative of at least of three independent experiments.
Quantitation of migration and the effects of Kibra knock-down and overexpressed Kibra is summarized in panel (B). (C–D) Monolayers of NRK cells
were wounded 60 h post-transfection with the indicated siRNAs (10 nM). Cells were fixed 6 h after wounding with paraformaldhehyde,
permeabilized with 1% Triton6100, and then immunostained for PKCf/i, PKCi, Kibra, and actin (Phalloidin).
doi:10.1371/journal.pbio.1000235.g004
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PLoS Biology | www.plosbiology.org 8 November 2009 | Volume 7 | Issue 11 | e1000235Figure 5. aPKC-dependent JNK1, ERK2, and MKK4 activation are required for NRK cell migration. (A) Monolayers of confluent NRK cells
were extensively scratched to maximize the number of ‘‘free edges’’ where cell-cell contacts were released. Cells were treated with PKC inhibitors
(Go ¨6976 or Go ¨6983 at 5 mM) for a total of 6 h, with extracts made at the indicated intervals post-wounding. Phospho-JNK1/2, total JNK1/2, phospho-
MKK4, total MKK4, phospho MKK7, and total MKK7 were detected by Western blotting. (B,C,D) Monolayers of NRK cells were wounded 60 h post-
transfection with the indicated siRNAs (10 nM). Cells were fixed 6 h after wounding with paraformaldhehyde, permeabilized with 1% Triton6100, and
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Membrane Substrate Paxillin but not of Its Nuclear
Substrate, c-Jun
The above evidence is indicative of a localised MKK4-
dependent activation of JNK1 during cell migration, requiring
the localised action of the aPKC-Kibra-Exocyst complex. To
assess the specificity of these plasma membrane effects in relation
to other compartments, we compared the aPKC-dependency of
the phosphorylation of nuclear (c-Jun) and plasma membrane
(Paxillin) both substrates for JNK [31]. The aPKC inhibitor
Go ¨6983 blocked the phosphorylation of Paxillin on serine 178 but
not of c-jun serine 63 (Figure 6A). Furthermore, siRNA directed
against aPKCs or Sec5 does not decrease phospho-cJun in the
nucleus (Figure S6E). The lack of effect on Jun phosphorylation is
consistent with the fact that phospho-JNK in the nucleus is not
modified after depletion of aPKCs (see Figure 5B). Demonstrating
that these events are integral to the observed migratory response, it
was shown that the depletion of ERK2 but not ERK1, depletion of
JNK1 but not JNK2, and depletion of MKK4 (and also MKK7)
significantly decreased cell migration (Figure 5E and 5F) as did the
JNK inhibitor, SP600125 (Figure S7H and S7I; the controls for
depletion are included in Figure S7C and S7F).
To address the effect of the absence of aPKC and Exocyst on
Paxillin in migrating NRK cells, cells were stained for Paxillin and
Actin. More Paxillin patches at focal adhesion complexes and also
more actin stress fibres appeared in the absence of aPKC and the
Exocyst (Figure 6B; quantified in Figure S9). Figure 6C shows that
P-JNK colocalised with Paxillin and if the aPKC/Exocyst pathway
is disrupted, P-JNK at the leading edge is abolished whereas there
is an increase of Paxillin patches. This increase of Paxillin patches
was mirrored with siRNAs against ERK2 and JNK1 consistent
with the requirement for Exocyst/aPKC in the localised activation
of ERK1/2 and JNK1 and the consequent distribution of Paxillin
in focal adhesion complexes as opposed to the more static focal
adhesion complexes. ERK1, ERK2, and JNK1 were depleted and
the effect of their depletion on Paxillin Patches were quantified.
Depletion of ERK2 and JNK1 and not ERK1 elicited an increase
of Paxillin patches.
Discussion
It is established here that aPKC isoforms via the Exocyst
complex can confer efficient migration through their ability to
control the leading edge activation of a distinct subpopulation of
MAPKinases, conferring increased speed on the serum-dependent
migratory response of cells. This localised process is enabled
through the traffic of an aPKC-Exocyst complex to the leading
edge of migrating cells. Assembly of this complex is dependent
upon Kibra, which appears to act as a scaffold linking aPKC
[17,22] with Sec3 through non-overlapping binding domains.
Whilst assembly is not dependent upon aPKC activity, it is
promoted by migratory conditions and immuno-isolation of the
Exocyst-aPKC complex demonstrates that the associated aPKC is
catalytically active. The Exocyst complex is required for aPKC
accumulation at the leading edge. Reciprocally, the association of
the Exocyst with active aPKC correlates with a requirement for
aPKC expression and activity for the traffic of the Exocyst to the
leading edge of migrating cells. The Exocyst-Kibra-aPKC
complex traffics in a microtubule-dependent fashion to the leading
edge of migrating NRK cells and this is a necessary event to
promote efficient/directed migration. The control of aPKCs on
the Exocyst at the leading edge could be explained by control of
microtubule dynamics by aPKC as suggested previously [32].
Consistent with this pattern of behaviour, knock-down of Exocyst
subunits or aPKC isoforms, or inhibition of aPKC isoforms
(Go ¨6983, a pan-PKC inhibitor) inhibits migration.
The migratory model itself requires the presence of serum and
matrix interactions for migration. For NRK cells, migration occurs
on fibronectin, laminin, and collagen with all three displaying a
requirement for aPKC for optimum migration. By contrast in
RPE1 cells, migration on fibronectin is aPKC-dependent but on
laminin or collagen migration is relatively insensitive to knock-
down of aPKC. As evident from the NRK cell model here, which
is 60% dependent on aPKC, there are multiple modes of
migration that display differential dependence on control mech-
anisms and these vary between cells.
Mechanistically, the aPKC-Exocyst assembly in the NRK cell
model confers JNK and ERK activation at the leading edge and
furthermore JNK1 (and not JNK2) as well as ERK2 (and not
ERK1) inhibition blocks cell migration. JNK’s effects appear to be
mediated in part through the phosphorylation of Paxillin on serine
178, determining the dynamics of focal adhesions [31,33]. aPKCs
also control the phosphorylation of Paxillin by ERK1/2 on serine
126 (unpublished data). These phosphorylations were described to
be important for the turnover of Paxillin at the focal adhesions
[27,31,33,34]. Indeed, the knock-down of aPKCf/i or Sec5 (or
Exo84) causes Paxillin accumulation in large, static focal
adhesions. Thus we have mapped a pathway from the assembly
of the aPKC-Exocyst complex, through their mutual delivery to
the leading edge of migrating cells, the activation there of ERK
and JNK, and the consequent phosphorylation of Paxillin,
influencing the dynamics of focal adhesion turnover and
migration. Video microscopy experiments (Videos S1 and S2)
are compatible with the regulation of Paxillin dynamics being
under aPKC control. Co-immunoprecipitation experiments
showed also an interaction between Sec8 and Paxillin in NRK
cells. Paxillin was shown recently as a partner of Sec5 [35]. This
interaction between Sec8 and Paxillin increased during NRK cell
migration (Figure 6). These data suggest that there is an acute
regulation of Paxillin by aPKC.
The action of aPKCs in conferring this promigratory behaviour
reflects their role in directing the subcellular localisation of signals.
Such spatially resolved behaviour of cellular regulators is
increasingly recognised as a critical factor in determining the
nature of their output. Here the evidence is for the localised action
of the JNK pathway (in particular JNK1) in migration. The
depletion of JNK1 decreases the P-JNK staining at the leading
edge. Only JNK1 and not JNK2 knock-down inhibits cell
migration and Go ¨6983 inhibits only the phosphorylation of
JNK1 and not JNK2 during cell migration. These three
observations provide compelling evidence that JNK1 is a key
player in the JNK pathway responsible for aPKC-dependent NRK
cell migration. Activation of JNK1 at the leading edge, effected
through the aPKC-Kibra-Exocyst complex, is necessary for the
phosphorylation of Paxillin in this compartment, while the
migration-associated, JNK-dependent phosphorylation of nuclear
c-jun is immune to aPKC-Kibra
2-Exocyst function. Conversely it
is evident that the activated JNK engaged in c-jun phosphorylation
then immunostained for P-JNK, P-ERK, and actin (Phalloidin) as indicated in the individual panels. (B) Each image is the sum of the z-stack of confocal
slices. (C–D) Each image is a zoom and one confocal slice. (E–F) Quantitation of migration speed and the effects of MKK4, MKK7, JNK1, JNK2, ERK1,
and ERK2 knock-down is summarized in the panel. The controls monitoring the depletion of these proteins are presented in Figure S7.
doi:10.1371/journal.pbio.1000235.g005
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PLoS Biology | www.plosbiology.org 10 November 2009 | Volume 7 | Issue 11 | e1000235Figure 6. During cell migration aPKCs and the exocyst control the phosphorylation and the stability of paxillin at focal adhesions.
(A) Monolayers of confluent NRK cells were extensively scratched to maximize the number of ‘‘free edges’’ where cell-cell contacts were released.
Cells were treated with PKC inhibitors (Go ¨6976 or Go ¨6983 at 5 mM) for a total of 6 h, with extracts made at the indicated intervals post-wounding.
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the plasma membrane (Figure 7). The aPKC-dependent plasma
membrane activation of both JNK and ERK is driven by delivery
of upstream controls and not through the localisation of the JNK
or ERK proteins themselves (Figure 7). This lack of effect on ERK
and JNK recruitment at the leading edge when the Exocyst-
aPKCs is disrupted by various siRNAs shows that a leading edge is
preserved; aPKC/Exocyst disruption does not disorganise globally
the leading edge, and cells still retain oriented protrusions.
Moreover, the distribution of the actin cytoskeleton of migrating
cells at the wound edge is retained as described by Guo et al. using
siRNA against Exo70 [15]. These MAPKinases along with
characteristic cortical actin structures retain their leading edge
location independent of aPKC-Kibra-Exocyst action and their
activation by phosphorylation. It is implicit that the polarised
delivery and/or retention of these MAPKinases at the leading
edge is dependent on distinct non-aPKC signal(s).
The upstream signals required for the activation of JNK appears
to involve MKK4 and not MKK7 since the former shows
sensitivity to inhibition of aPKC (pan-PKC) in its migration-
induced activation, while the latter is insensitive. Although the
depletion of MKK4 inhibits cell migration consistent with the
proposed role for MKK4, so does the depletion of MKK7,
preventing distinction to be made between these two JNK kinases.
However, it is notable that the morphology of cells depleted of
MKK4 (but not of MKK7) is a phenocopy of the cells depleted of
aPKC (bigger, more spread cells), consistent with the selective
effects of aPKC inhibition on MKK4; cells depleted of MKK7
displayed a stressed appearance after wounding that was quite
distinct from the morphological phenotype of MKK4 and aPKC
knock-down cells. It is concluded that MKK7, though not
activated during migration, is probably required for migration in
an aPKC independent pathway.
PKCi can control JNK via Par6 and Rac [36], however the
control exerted during cell migration via MEK4 remains under
investigation. HGK, a MAPKKKKinase specific for the JNK
pathway, was described to interact with the Exocyst complex [37].
So one possibility is that aPKCs could control the interaction of
HGK with Exocyst complex. Although the Exocyst has been
associated with secretory events, the upstream trigger for
activation is not thought to be dependent upon any factor(s)
secreted following movement of the Exocyst to the leading edge,
Phospho-cJun (ser63), phospho-Paxillin (ser178), total cJun, and total Paxillin were detected. (B) Monolayers of NRK cells were wounded 60 h post-
transfection with the indicated siRNAs (10 nM). Cells were fixed 6 h after wounding with paraformaldhehyde, permeabilized with 1% Triton6100, and
then immunostained for actin (Phalloidin) and Paxillin as indicated in the individual panels. Each image is a projection of confocal slices. (C)
Monolayers of NRK cells were wounded 60 h post-transfection with the indicated siRNAs (20 nM). Cells were fixed 6 h after wounding with
paraformaldhehyde, permeabilized with 1% Triton6100, and then immunostained for P-JNK1/2 and Paxillin as indicated in the individual panels. Each
image is a confocal slice. (D) A monolayer of confluent NRK cells was extensively scratched to maximize the number of ‘‘free edges’’ where cell-cell
contacts were released. Sec8 was immunoprecipitated and Paxillin was detected by Western blot.
doi:10.1371/journal.pbio.1000235.g006
Figure 7. Schematic representation of the aPKC-exocyst complex in cell migration. The Exocyst-Kibra-aPKC complex controls the
activation, but not the localisation of JNK1 and ERK1/2 at the leading edge, via a microtubule dependent process. The active JNK1 and ERK1/2 can
then phosphorylate the common substrate, Paxillin, determining the stability of focal adhesion dynamics. By contrast, the activation of JNK2 and c-
Jun in the nucleus during cell migration is independent of the Exocyst-aPKC pathway.
doi:10.1371/journal.pbio.1000235.g007
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wounded cells where the Exocyst subunit Sec5 has been knocked
down (Figure S3E, S3F). It would appear that the trigger for
activation derives from changes in cell-cell/matrix interactions
triggered by removal of cells from the monolayer (wounding).
In conclusion, aPKCs via the Exocyst complex and Kibra are
shown to exert a pro-migratory role in NRK cells and do so
through the regulated delivery of a signal to the leading edge of
migrating cells through kinases upstream of JNK1 and ERK1/2.
This regulation of the ERK and JNK pathways via aPKCs allows
the phosphorylation of a common substrate, Paxillin (Figure 7),
and consequently probably the turnover of Paxillin at the focal
adhesion sites. The combined actions of this complex thus
integrate the polarised, leading edge delivery of signals required
for efficient migration.
Material and Methods
Cell Culture and Wound Assay
Normal rat kidney (here denoted NRK, but specifically NRK-
49F cells, confirmed by ß-catenin staining [38]; Figure S3A) cells
were cultivated in Dulbecco’s modified Eagle medium and 10%
fetal calf serum under 5% CO2 on Falcon plastic dishes. Wounds
were inflicted by scratching the cell surface with a plastic pipette
tip. Images were recorded using a Zeiss microscope and an Orca
ER CCD camera (Hamamatsu). All inhibitor treatments were
performed without pre-incubation. Quantification of the speed of
individual cells was performed using Metamorph, Tracker, and
Mathematica software.
Immunofluorescence
Cells were fixed in 4% paraformaldehyde (unless stated
otherwise), permeabilized in 1% Triton X-100, and mounted
using Prolong (Molecular Probes). Primary antibodies were
obtained from Stressgen (Sec6), BD Bioscience (Sec8), Cell
Signaling (phospho-extracellular signal-regulated kinase 1/2; P-
ERK1/2, P-JNK1/2, P-cJun), or Sigma (fluorescein isothiocya-
nate (FITC)-coupled anti-tubulin). The antibody anti-Exo70 was
generously provided by Dr. S. C. Hsu (Department of Cell Biology
and Neuroscience, Rutgers University, Piscataway, New Jersey,
USA). Secondary antibodies were from Jackson Laboratories and
Molecular Probes and were coupled to Cy3 and FITC,
respectively. Images were acquired using a confocal laser scanning
microscope (LSM510, Carl Zeiss Inc.) equipped with a 636/1.4
Plan-Apochromat oil immersion objective. Alexa 488 was excited
with the 488-nm line of an argon laser, Cy3 was excited with a
543-nm HeNe laser, and Cy5 was excited with a 633-nm HeNe
laser. Each image represents a projection or a single section as
indicated in the Figure legend.
Analysis of the Immunofluorescence Data
For experiments involving protein recruitment at the leading
edge, at least 70 cells at the wound were counted per experiment
according the classification shown in Figure S2. Each figure shows
the quantified recruitment of the specified protein at the leading
edge from at least three independent experiments.
Where Paxillin spots and Actin stress fibers were quantified, an
Array Scan II and the Cellomics analysis program were employed.
Each cell was identified by nuclear staining (Dapi) and actin
staining (phalloidin). Each area of interest for the analysis (spot or
fiber) was delimited and represented as an object. The number of
Paxillin spots as well as the total area of stress fibers per cell were
measured (Figure S10B).
Immunoprecipitation and Immunodetection
For whole-cell extracts, cells were lysed directly on plates in hot
Laemmli sample buffer. For immunoprecipitation, cells were lysed
in 20 mM Tris-HCl (pH 7.4), 100 mM NaCl, 1 mM MgCl2,
0.1 mM dithiothreitol, 1% Triton X-100, and 10% glycerol;
antibodies were used at the concentrations recommended by
suppliers for immunoprecipitation or for immunodetection on
membranes. Proteins were visualized on membranes with a
chemiluminescent detection system (ECL; Amersham). Quantita-
tion of the immunoprecipitates were performed using Image J.
Primary antibodies were obtained from Santa Cruz (PKCf/i,
JNK1/2, Paxillin), BD Biosciences (PKCi and rSec8), UBI
(ERK1/2), cell signaling (P-MKK4, MKK4, P-MKK7, MKK7,
P-JNK1/2, P-ERK1/2), or Calbiochem (Phospho-Paxillin
[ser178]). The Phospho-SAPK/JNK (Thr183/Tyr185) Blocking
Peptide was obtained from Cell Signaling. The different inhibitors
(Go ¨6976, Go ¨6983, BIM-I, SP600125, and UO126) were obtained
from Calbiochem. For ‘‘scratch tests,’’ NRK cells were brought to
confluence and scratched orthogonally at least 20 times with a
p20-200 yellow tip. Cells were either further incubated for 3 h or
harvested immediately. Preparations of cell extracts and co-
immunoprecipitation were performed according to published
procedures [16]. For detection of the activation of ERK1/2,
JNK1/2, c-Jun, and MKK4, cells were scratched, allowed to
migrate for different times (as indicated), and then harvested in
Laemmli sample buffer, boiled, and processed for Western
blotting. For direct comparison all cells were maintained in
contact with the inhibitors for a 3 or 6 h period as indicated in the
text or figure legends.
Two Hybrid Screen
Full-length human Sec3 was cloned into pB27, derived from the
original pBTM116 plasmid [39], and used as bait to screen a
random-primed human placenta cDNA library constructed in pP6
[40]. A total of 120 million clones (12-fold library coverage) were
screened using a mating approach with L40DGal4 (mata) and
Y187 (mata) yeast strains [41]. His+ colonies were selected on
medium lacking tryptophan, leucine, and histidine, supplemented
with 2mM 3-aminotriazole to reduce bait autoactivation. Prey
fragments of the positive clones were amplified by PCR and
sequenced at their 59 and 39 junctions on a PE3700 Sequencer.
The resulting sequences were used to identify the corresponding
interactors in the GenBank database (NCBI) using a fully
automated procedure.
siRNAs and Plasmid Constructs
siRNAs were transfected at 10 nM with Hyperfect (Qiagen)
according to the recommendations of the manufacturer. siRNA
were ordered from Dharmacon (rPKCf-1) or Proligo (the others).
Target sequences were:
GCAAGCUGCUUGUCCAUAAdTdT(rPKCf-1),
GCAAACUGCUGGUUCAUAAdTdT (rPKCi-1),
GAAGAAAGAGCUCGUCAAUdTdT (rPKCi-2),
GCAGUGAGGUUCGAGAUAUdTdT (rPKCi-3),
GAACGAUGGUGUAGACC U UdTdT (rPKCf-2).
Sequences for Sec5 were described previously [16]. The
sequence for Exo84 is UGGGCAUGUUCGUGGAUGCdTdT.
A smart-pool untargeted plus from Dharmacon was used to
deplete rat Kibra and independent siRNAs against rKibra
AGGAGAUCUACCAGGUGAAdTdT (Kibra-330), AGCAC-
GACUACAGUUCAAdTdT (rKibra-1), and CCACUCAC-
CUUUGCUGACUdTdT (rKibra-2) were also employed. Myc-
PKCf and PKCi constructs were described previously [42]. Myc-
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[17,22].
The siRNA for the JNK and ERK pathways were obtained
from Qiagen; siJNK1 (SI03083185 and SI03105802) and a smart
pool from Dharmacon was also used to deplete rat JNK1, siJNK2
(SI01906310 and SI02723588), siERK1 (SI01300593 and
SI01906163), siERK2 (SI02672117 and SI02692326), siMKK4
(SI01533791 and SI01533798), and siMKK7 (SI04404680 and
SI04404687).
Supporting Information
Figure S1 Controls for the recruitment of Exo70 and PKCi at
the leading edge. (A–B) Confluent monolayers of NRK cells were
wounded (top panels) or cultivated at 70% confluence (lower
panels). Cells were fixed 3 h after wounding with paraformaldhe-
hyde, permeabilized with 1% Triton6100, and then immuno-
stained for Exo70, PKCi, and a cytoplasmic tracker (Molecular
Probe) as indicated in the individual panels. Each image is a
projection of confocal slices. Only in migrating conditions (red
arrows), Exo70 and PKCi are recruited at the edge of the cells.
There is no recruitment of Exo 70 or of PKCi in non migrating
cells (grey arrows).
Found at: doi:10.1371/journal.pbio.1000235.s001 (7.03 MB TIF)
Figure S2 Quantification of the recruitment at the leading edge
of Exo70 and PKCi after depletion of aPKC or a component of
the Exocyst (Sec5 or Exo84). (A) Schematic representation
illustrating how the cells at the leading edge were quantified. (2)
no recruitment at the leading edge, (+) partial recruitment at the
leading edge, (++) total recruitment at the leading edge. (B)
Quantification of PKCi at the leading edge. (C) Quantification of
Exo70 at the leading edge.
Found at: doi:10.1371/journal.pbio.1000235.s002 (1.32 MB TIF)
Figure S3 The influence of aPKC on the Exocyst and migration
is independent of CDC42 and does not reflect a general secretory
or membrane traffic effect. (A) A monolayer of NRK cells was
fixed with paraformaldhehyde and b-Catenin and Paxillin
detected by immunofluorescence. (B) Monolayers of NRK cells
were wounded 60 h post-transfection with the indicated siRNAs
(10 nM). (C) Monolayers of NRK cells were wounded and stained
for Sec6 and b-COP. Monolayers of NRK cells were wounded
60 h post-transfection with the indicated siRNAs (10 nM). Cells
were fixed with methanol 60 h after wounding and stained for
Sec6 and beta-COP. The images are projections of confocal
sections. (D) Monolayers of NRK cells overexpressing dominant
negative Myc-CDC42 were wounded and stained for Exo70 and
Myc. Cells were fixed with paraformaldhehyde 6 h after wounding
and Exo70 detected by immunofluorescence. (E) Quantitation of
migration speed and the effects of Sec5 knock-down with or
without different conditioned media are summarized in the panel.
(F) Controls illustrating Sec5 depletion relating to Panel E. NRK
cells were transfected with the indicated siRNA, and after 72 h,
whole-cell extracts were analyzed by immunoblotting.
Found at: doi:10.1371/journal.pbio.1000235.s003 (9.34 MB TIF)
Figure S4 Interaction between the Exocyst and PKCf and
PKCi via Kibra is independent of aPKC activity, but aPKC
activity is required for ERK1/2 activation in migrating NRK cells.
(A,B) Protein extracts from NRK cells over-expressing PKCi (A)
or a myc tag PKCf construct (B) were subjected to immunopre-
cipitation with an anti-Sec8 antibody, and the immunoprecipitates
were analyzed for the presence of PKCi or mycPKCf by Western
blotting. (C) Protein extracts from NRK cells were subjected to
immunoprecipitation with an anti-Sec8 antibody in the presence
or absence of the aPKC inhibitor Go ¨6983. The immunoprecip-
itates were analyzed for the presence of endogenous PKCf/i and
PKCi. (D) Monolayers of confluent NRK cells were extensively
scratched to maximize the number of ‘‘free edges’’ where cell-cell
contacts were released. As indicated NRK cells were pre-treated
with the c/n/aPKC inhibitor (Go ¨6983 at 1 or 5mM) for a total of
6 h. Extracts were prepared at the times indicated, and Phospho-
JNK1/2, phospho-ERK1/2, total JNK1/2, total ERK1/2,
phospho-p38, Sec8, Sec5, aPKC, and PKCi were detected by
Western blotting. (E) NRK cells were treated with PKC inhibitors
(Go ¨6976 and Go ¨6983 at 5 mM) for a total of 6 h. Cell extracts
were prepared at the times indicated and Phospho-ERK1/2 and
total ERK1/2 were detected.
Found at: doi:10.1371/journal.pbio.1000235.s004 (0.99 MB TIF)
Figure S5 Depletion of Kibra or Exo84 disrupts the local
phosphorylation of JNK and ERK at the leading edge; depletion
of Sec5 or aPKC does not modify the plasma membrane delivery
of ERK1/2, JNK1/2 proteins, or the phosphorylation of nuclear
cJun during cell migration. (A) Monolayers of NRK cells were
wounded 60 h post-transfection with the indicated siRNAs
(10 nM). Cells were fixed 6 h after wounding with paraformald-
hehyde, permeabilized with 1% Triton6100, and then immuno-
stained for P-JNK, P-ERK, and actin (Phalloidin) as indicated in
the individual panels. Each image is a projection of confocal slices.
(B) Monolayers of NRK cells were wounded. Cells were treated for
the 3 h of migration with UO1206 (20 mM). Cells were then fixed
with paraformaldhehyde, and P-ERK1/2 and actin (Phalloidin)
were detected with specific antibodies. (C,D,E,F) Monolayers of
NRK cells were wounded 60 h post-transfection with the indicated
siRNAs (10 nM). (C) Cells were fixed with paraformaldhehyde 6 h
after wounding and JNK1/2 detected by immunofluorescence. (D)
Cells were fixed with methanol 6 h after wounding and ERK1/2
was detected by immunofluorescence. (E) Cells were fixed with
paraformaldhehyde 6 h after wounding and P-cJun detected by
immunofluorescence. (F) Cells were fixed with methanol 6 h after
wounding and ERK1/2 and P-ERK1/2 were detected by
immunofluorescence.
Found at: doi:10.1371/journal.pbio.1000235.s005 (4.96 MB TIF)
Figure S6 Interaction between Sec8, aPKC, and ectopic Kibra;
localization of Kibra in migrating cells. (A) Protein extracts from
NRK cells over-expressing Flag-Kibra were subjected to immu-
noprecipitation with an anti-Flag antibody and the immunopre-
cipitates were analyzed for the presence of aPKC and Sec8 by
Western blotting. (B) A monolayer of confluent NRK cells over-
expressing Myc-Kibra was extensively scratched to maximize the
number of ‘‘free edges’’ where cell-cell contacts were released.
Sec8 was immunoprecipitated and Myc Kibra was detected by
Western blot. (C) Monolayers of NRK cells were wounded 48 h
post-transfection with a Flag-Kibra construct. Cells were fixed
with paraformaldhehyde 3 h after wounding and Flag-Kibra and
aPKC were detected by immunofluorescence. (D) Control of the
experiment Figure 3H. NRK cells were transfected with a siRNA
against Kibra or an siRNA control as indicated. After 72 h of
transfection, the 1% (v/v) Triton6100 soluble fractions were
analyzed by immunoblotting with the indicated antibodies.
Found at: doi:10.1371/journal.pbio.1000235.s006 (4.64 MB TIF)
Figure S7 Controls for the depletion by siRNAs of aPKCs, the
Exocyst, ERK, MKK and JNK proteins, and immunostaining of
P-ERK and P-JNK. (A, B, C, D, E) siRNA specificity and
efficiency in NRK cells. NRK cells were transfected with the
indicated siRNAs, and after 72 h whole-cell extracts were
analyzed by immunoblotting with the indicated antibodies. (F)
Monolayers of NRK cells were wounded and were fixed with
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2 were detected by immunofluorescence. The antibodies were
preincubated with or without a phospho-peptide competitor of P-
JNK1/2 (0.1 mg/ml). (G) Monolayers of NRK cells were wounded
60 h post-transfection with the indicated siRNAs (20 nM). Cells
were fixed with paraformaldhehyde 6 h after wounding, and P-
JNK1/2 and P-ERK1/2 were detected by immunofluorescence.
(H) NRK cells were treated with the MEK inhibitor UO126
(10 mM) or with the JNK inhibitor SP600125 (20 mM). P-cJun
(ser63), P-Paxillin (ser178), and total cJun were detected. (I) After
6 h of treatment with SP600125 at 20 mM to inhibit JNK activity,
confluent monolayers of NRK cells were wounded. The healing
was followed for a further 12 h. T0 and T12 refer respectively to
0 h and 12 h post-wounding. The panels shown are representative
at least of three independent experiments.
Found at: doi:10.1371/journal.pbio.1000235.s007 (4.40 MB TIF)
Figure S8 Quantification of the recruitment to the leading edge
of P-ERK, Total ERK, P-JNK, and total JNK after depletion of
aPKC or one component of the Exocyst (Sec5 or Exo84). (A)
Schematic representation illustrating how the cells at the leading
edge were quantified. (2) no recruitment at the leading edge, (+)
partial recruitment at the leading edge, (++) total recruitment at
the leading edge. (B) Quantification of P-ERK and total ERK at
the leading edge. (C) Quantification of P-JNK and total JNK at
the leading edge.
Found at: doi:10.1371/journal.pbio.1000235.s008 (1.73 MB TIF)
Figure S9 Quantification of number of spots of Paxillin per cell
and the area of stress fibers after depletion of aPKC or one
component of the Exocyst (Sec5 or Exo84). (A,B) In a 96 well
plate, NRK cells were transfected with siRNA against aPKCs,
Sec5, Exo84, or an siRNA control as indicated. After 48 h of
transfection, cells were split and re-plated on fibronectin. The day
after (72 h post-transfection), cells were fixed in paraformaldehyde
4% and stained for paxillin and actin (phalloidoin). The staining
was analysed by Array Scan II and a Cellomics analysis program.
(A) Quantification of the number of spots of Paxillin per cell. (B)
Quantification of the area of stress fibers per cell.
Found at: doi:10.1371/journal.pbio.1000235.s009 (1.24 MB TIF)
Figure S10 Quantification of the number of spots of Paxillin per
cell and the area of stress fibers after depletion of JNK1, ERK1, or
ERK2 (as indicated). (A) In a 96 well plate, NRK cells were
transfected with a siRNA against JNK1, ERK1, ERK2, or a
siRNA control as indicated. After 48 h of transfection, cells were
split and re-plated on fibronectin. The day after (72 h post-
transfection), cells were fixed in paraformaldehyde 4% and stained
for paxillin and actin (phalloidoin). The staining was analysed by
Array Scan II and a Cellomics analysis program. The panel
indicates the quantification of the number of spots of Paxillin per
cell. (B) Illustration of the quantification of Paxillin and actin
(phalloidin stained) structures. In a 96 well plate, NRK cells were
transfected with siRNAs. After 48 h, cells were split and re-plated
on fibronectin. The following day (72 h post-transfection), cells
were fixed in paraformaldehyde (4%) and stained for paxillin,
nuclei (dapi), and actin (phalloidoin). The staining was analysed by
Array Scan II and a Cellomics analysis program: Each cell was
identified by nuclear staining and actin staining. The area of
interest for the analysis (spot or fiber) was delimited and
represented as an object (Masks). The number of Paxillin spots
as well as the total area of stress fibers per cell were measured.
Found at: doi:10.1371/journal.pbio.1000235.s010 (4.38 MB TIF)
Video S1 Dynamics of GFP-Paxillin during cell migration
(control). Monolayers of NRK cells were wounded 60 h post-
transfection with siRNA (20 nM) against Luciferase and 48 h post-
transfection with GFP-Paxillin. A TIRF microscope was used, and
images were taken every minute during 1 h.
Found at: doi:10.1371/journal.pbio.1000235.s011 (0.40 MB
MOV)
Video S2 Dynamics of GFP-Paxillin during cell migration in
absence of aPKC. Monolayers of NRK cells were wounded 60 h
post-transfection with siRNA (20 nM) against PKCf/i and 48 h
post-transfection with GFP-Paxillin. A TIRF microscope was used,
and images were taken every minute during 1 h.
Found at: doi:10.1371/journal.pbio.1000235.s012 (0.37 MB
MOV)
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